SCOPE 2023: Future Areas of Investment in Clinical Trials


In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures speaks about how the clinical trials sector is evolving, specifically with increased investment in decentralized trials and recent technological advancements such as artificial intelligence and digital biomarkers.

Related Videos
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.